Status:
COMPLETED
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
Lead Sponsor:
Tongji Hospital
Collaborating Sponsors:
LinkDoc Technology (Beijing) Co. Ltd.
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
A study to evaluate effectiveness of sublobar dissection in patients with non-small cell lung cancer
Detailed Description
This is a multi-centre real-world non-interventional observational study. The study data on patient demographic/tumor biological characteristics and clinical treatments were retrospectively collected ...
Eligibility Criteria
Inclusion
- Patients \>= 18 years old;
- Patients who received sublobar dissection from 2014 to 2017 (segment dissection/wedge dissection/segment and wedge dissections);
- Patients who received selective or systematic lymphadenectomy;
- Pathologically diagnosed patients with non-small cell lung cancer;
- Pathological staging: I, II
Exclusion
- Patients who received cancer treatments before surgeries (adjuvant therapies including chemotherapies, radiotherapies, target therapies);
- Patients who received late-phase or intolerant palliative lobectomy or compromise sublobar dissection;
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
3902 Patients enrolled
Trial Details
Trial ID
NCT03427567
Start Date
December 1 2017
End Date
March 30 2018
Last Update
May 21 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
China PLA General Hospital
Beijing, Beijing Municipality, China, 100853
3
Henan cancer hospital
Zhengzhou, Henan, China, 450003
4
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China, 430030